UPDATE 17. June 2020: Flu shot in over 65y old people and almost certain death due to corona contagion

Pentagon Study: Flu Shot Raises Risk of Coronavirus by 36% (and Other Supporting Studies)

By Robert F. Kennedy, Jr. - 16. April 2020

On March 12th, 2020, Anderson Cooper and Dr. Sanjay Gupta held a global town hall on “Corona Facts and Fears.” During the discussion, Anderson said to the viewing audience, “And, again, if you are concerned about coronavirus, and you haven’t gotten a flu shot…you should get a flu shot.”

Setting safety and efficacy of influenza vaccination aside, is Anderson’s claim that the flu shot will help people fight COVID-19 remotely true? The short answer is no.

In fact, the results of many peer-reviewed, published studies prove that Anderson’s recommendation may have been the worst advice he could have given the public.

In searching the literature, the only study we have been able to find assessing flu shots and coronavirus is a 2020 US Pentagon study that found that the flu shot INCREASES the risks from coronavirus by 36%. “Receiving influenza vaccination may increase the risk of other respiratory viruses, a phenomenon known as “virus interference…’vaccine derived’ virus interference was significantly associated with coronavirus…” Here are the findings:

2020 Pentagon study: Flu vaccines increase risk of coronavirus by 36% 

Examining non-influenza viruses specifically, the odds of coronavirus in vaccinated individuals were significantly higher when compared to unvaccinated individuals with an odds ratio (association between an exposure and an outcome) of 1.36. In other words, the vaccinated were 36% more likely to get coronavirus.

 

Many other studies suggest the increased risk of viral respiratory infections from the flu shot:

2018 CDC Study: Flu shots increase risk of non-flu acute respiratory illnesses (ARI) in children.

This CDC supported study concluded an increased risk of acute respiratory illness (ARI) among children <18 years caused by non-influenza respiratory pathogens post-influenza vaccination compared to unvaccinated children during the same period.

 

2011 Australian Study: Flu shot doubled risk of non-influenza viral infections and increased flu risk by 73%.

A prospective case-control study in healthy young Australian children found that seasonal flu shots doubled their risk of illness from non-influenza virus infections. Overall, the vaccine increased the risk of virus-associated acute respiratory illness, including influenza, by 73%.

 

2012 Hong Kong Study: Flu shots increased the risk of non-flu respiratory infections 4.4 times and tripled flu infections.

A randomized placebo-controlled trial in Hong Kong children found that flu shots increased the risk of non-influenza viral ARIs fivefold (OR 4.91,CI 1.04—8.14) and, including influenza, tripled the overall viral ARI risk (OR 3.17, CI 1.04—9.83).

 

2017 Study: Vaccinated children are 5.9 more likely to suffer pneumonia and 30.1 times more likely to have been diagnosed with Allergic Rhinitis than unvaccinated children.

Vaccinated children were 30.1 times more likely to have been diagnosed with Allergic Rhinitis and 5.9 times more likely to have been diagnosed with pneumonia than unvaccinated children.

 

2014 Study: Influenza-vaccinated children were 1.6 times more likely than unvaccinated children to have a non-influenza “Influenza-like-illness” (ILI).

Even more published science

The well-respected Cochrane Collaboration’s comprehensive 2010 meta-analysis of published influenza vaccine studies found that the influenza vaccination has “no effect” on hospitalization, and that there is “no evidence that vaccines prevent viral transmission or complications.” The Cochrane Researchers concluded that the scientific evidence “seem[s] to discourage the utilization of vaccination against influenza in healthy adults as a routine public health measure.” 

In their meta-analysis, the Cochrane researchers accused the CDC of deliberately misrepresenting the science in order to support their universal influenza vaccination recommendation. Nevertheless, CNN and other mainstream media outlets continually broadcast CDC pronouncements as gospel and, ironically, ridicules those of us who actually read the science as “purveyors of ‘vaccine misinformation”.

Author:

Robert F. Kennedy, Jr. is the Chairman of Children’s Health Defense

===

IMPORTANT UPDATE

Flu vaccination ratio in over 65y old and death rate due to SARS-CoV-2 per country

===

. 2020 Jan 10;38(2):350-354. doi: 10.1016/j.vaccine.2019.10.005. Epub 2019 Oct 10.

Influenza Vaccination and Respiratory Virus Interference Among Department of Defense Personnel During the 2017-2018 Influenza Season

Greg G Wolff 1

Abstract

Purpose: Receiving influenza vaccination may increase the risk of other respiratory viruses, a phenomenon known as virus interference. Test-negative study designs are often utilized to calculate influenza vaccine effectiveness. The virus interference phenomenon goes against the basic assumption of the test-negative vaccine effectiveness study that vaccination does not change the risk of infection with other respiratory illness, thus potentially biasing vaccine effectiveness results in the positive direction. This study aimed to investigate virus interference by comparing respiratory virus status among Department of Defense personnel based on their influenza vaccination status. Furthermore, individual respiratory viruses and their association with influenza vaccination were examined.

Results: We compared vaccination status of 2880 people with non-influenza respiratory viruses to 3240 people with pan-negative results. Comparing vaccinated to non-vaccinated patients, the adjusted odds ratio for non-flu viruses was 0.97 (95% confidence interval (CI): 0.86, 1.09; p = 0.60). Additionally, the vaccination status of 3349 cases of influenza were compared to three different control groups: all controls (N = 6120), non-influenza positive controls (N = 2880), and pan-negative controls (N = 3240). The adjusted ORs for the comparisons among the three control groups did not vary much (range: 0.46-0.51).

Conclusions: Receipt of influenza vaccination was not associated with virus interference among our population. Examining virus interference by specific respiratory viruses showed mixed results. Vaccine derived virus interference was significantly associated with coronavirus and human metapneumovirus; however, significant protection with vaccination was associated not only with most influenza viruses, but also parainfluenza, RSV, and non-influenza virus coinfections.

Keywords: Department of Defense; Influenza vaccine; Respiratory illness; Virus interference.

Conflict of interest statement

The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

References

      1. National Vaccine Information Center. What is the History of Influenza Vaccine Use in America? <https://www.nvic.org/vaccines-and-diseases/influenza/vaccine-history.aspx> 2019.
      1. Treanor J.J., Talbot H.K., Ohmit S.E. Effectiveness of seasonal influenza vaccines in the United States during a season with circulation of all three vaccine strains. Clin Infect Dis. 2012;55(7):951–959. - PMC - PubMed
      1. Ohmit S.E., Thompson M.G., Petrie J.G. Influenza vaccine effectiveness in the 2011–2012 season: protection against each circulating virus and the effect of prior vaccination on estimates. Clin Infect Dis. 2014;58(3):319–327. - PMC - PubMed
      1. McLean H.Q., Thompson M.G., Sundaram M.E. Influenza vaccine effectiveness in the United States during 2012–2013: variable protection by age and virus type. J Infect Dis. 2015;211(10):1529–1540. - PMC - PubMed
      1. Jackson M.L., Chung J.R., Jackson L.A. Influenza Vaccine Effectiveness in the United States during the 2015–2016 Season. N Engl J Med. 2017;377(6):534–543. - PMC - PubMed
      1. Centers for Disease Control and Prevention. Seasonal Influenza Vaccine Effectiveness, 2004-2018. <https://www.cdc.gov/flu/professionals/vaccination/effectiveness-studies.htm> 22 February 2019.
      1. Suzuki M., Camacho A., Ariyoshi K. Potential effect of virus interference on influenza vaccine effectiveness estimates in test-negative designs. Epidemiol Infect. 2014;142:2642–2646. -PubMed
      1. Cowling B.J., Fang V.J., Peiris J.S.M. Increased risk of noninfluenza respiratory virus infections associated with receipt of inactivated influenza vaccine. Clin Infect Dis. 2012;54:1778–1783. -PMC - PubMed
      1. Feng S., Fowlkes A., Steffens A., Finelli L., Cowling B. Assessment of virus interference in a test-negative study of influenza vaccine effectiveness. Epidemiology. 2017;28(4):514–524. - PMC -PubMed
      1. Cowling B.J., Nishiura H. Virus interference and estimates of influenza vaccine effectiveness from test-negative studies. Epidemiology. 2012;23(6):930–931. - PubMed
      1. Rikin S., Jia H., Stockwell M. Assessment of temporally-related acute respiratory illness following influenza vaccination. Vaccine. 2018;36:1958–1964. - PMC - PubMed
      1. Sundaram M.E., McClure D.L., Belongia E.A. Influenza vaccination is not associated with detection of noninfluenza respiratory viruses in seasonal studies of influenza vaccine effectiveness. Clin Infect Dis. 2013 September;57:789–793. - PMC - PubMed
      1. Defense Health Agency . Defense Health Agency; Falls Church, Virginia: 2018. Seasonal Influenza Vaccination Program (IVP) pp. 1–23. Interim Procedures Memorandum 18-005.
      1. NxTAG Respiratory Pathogen Panel [package insert]. Toronto, Ontario, Canada: Luminex; 2016.
      1. Biofire FilmArray Respiratory Pathogen Panel [package insert]. Salt Lake City, Utah, USA; 28 June 2017.
      1. CDC Influenza A Subtyping Kit (Version 2) [package insert]. Atlanta, Georgia, USA; 22 July 2016.
      1. CDC Influenza A/B Subtyping Kit [package insert]. Atlanta, Georgia, USA; 23 March 2016.
      1. Foppa I., Haber M., Ferdinands J. The case test-negative design for studies of the effectiveness of influenza vaccine. Vaccine. 2013;31(June):3104–3109. - PubMed
      1. Jackson M., Nelson J. The test-negative design for estimating influenza vaccine effectiveness. Vaccine. 2013;31(April):2165–2168. - PubMed
      1. Foppa I., Ferdinands J., Chaves S. The case test-negative design for studies of the effectiveness of influenza vaccine in inpatient settings. Int J Epidemiol. 2016;6:2052. - PMC - PubMed
      1. Sullivan S., Tchetgen Tchetgen E., Cowling B. Theoretical basis of the test-negative study design for assessment of influenza vaccine effectiveness. Am J Epidemiol. 2016;5:345. - PMC - PubMed
      1. Coleman R., Eick-Cost A., Hawksworth A.W. Department of defense end-of-season influenza vaccine effectiveness estimates for the 2017–2018 season. MSMR. 2018;25(10):16. - PubMed
      1. Cooper M. DoD Influenza Surveillance and Vaccine Effectiveness. In: Oral presentation at: The Vaccines and Related Biological Products Advisory Committee (VRBPAC) Meeting; February 28, 2014; Silver Spring, MD.

Recent Articles

JUNE 19, 2020

CHD in the First Direct Debate with Telecom on 5G – Don’t Miss!

 

JUNE 19, 2020

TRUTH with Robert F. Kennedy, Jr., Episode 5

 

JUNE 18, 2020

Lessons from the Lockdown—Why Are So Many Fewer Children Dying?

 

JUNE 18, 2020

Historical Lapses in Public Health Ethics: Will Gates-Funded COVID Vaccine Human Trials Be Business as Usual?